Holocene Advisors
GILD icon

Holocene Advisors’s Gilead Sciences GILD Stock Holding History

Holocene Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.4M Buy
+700,000
New +$92.2M 0.2% 137
2025
Q3 		– Sell
-1,200,000
Closed -$133M – 813
2025
Q2 		$133M Buy
+1,200,000
New +$128M 0.32% 86
2021
Q2 		– Sell
-1,440,000
Closed -$93.1M – 871
2021
Q1 		$93.1M Buy
1,440,000
+480,000
+50% +$31M 0.58% 51
2020
Q4 		$55.9M Buy
+960,000
New +$57.9M 0.35% 95

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Holocene Advisors's GILD Position: Q2 2026 in Review

Holocene Advisors increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $79.7M and bringing the position to 3,216,892 shares worth $406M. The position accounts for 0.92% of the portfolio, ranked #17.

Holocene Advisors first reported a position in GILD in Q4 2017 and has held it in 11 quarters since. The position peaked at $511M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Holocene Advisors held 3,216,892 shares of Gilead Sciences worth $406M as of Q2 2026.
  • Holocene Advisors bought 605,066 Gilead Sciences shares in Q2 2026, an estimated $79.7M.
  • Gilead Sciences made up 0.92% of Holocene Advisors's portfolio in Q2 2026, its #17 holding.
  • Holocene Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 11 quarters since.
  • Holocene Advisors's Gilead Sciences position peaked at $511M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.